PPARG and thyroid gland carcinoma: Pioglitazone is an insulin sensitizer for type 2 diabetes with therapeutic effects in mouse models of thyroid cancer due to the fusion protein (PAX8-PPARg) present in 30% of thyroid cancer [46].